Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCIN: Surgical Excision vs. Curettage + Imiquimod for Nodular BCC
NCT02242929Phase 3Unknown
- Sponsor
- Maastricht University Medical Center+
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of imiquimod in basal cell carcinoma (BCC), sponsored by Maastricht University Medical Center+. Status: unknown.
02
Drugs
imiquimod
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT02242929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242929.